GSK
712 hedge funds and large institutions have $14.4B invested in GSK in 2014 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 286 increasing their positions, 210 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $14.4B → $14.4B (+$53M)
0.01% more ownership
Funds ownership: 4.42% → 4.43% (+0.01%)
33% less funds holding in top 10
Funds holding in top 10: 15 → 10 (-5)
Holders
712
Holding in Top 10
10
Calls
$116M
Puts
$69.1M
Top Buyers
| 1 | +$230M | |
| 2 | +$40.4M | |
| 3 | +$39.6M | |
| 4 |
Renaissance Technologies
New York
|
+$31.2M |
| 5 |
Goldman Sachs
New York
|
+$24.7M |
Top Sellers
| 1 | -$210M | |
| 2 | -$137M | |
| 3 | -$67.9M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$61.1M |
| 5 |
Primecap Management
Pasadena,
California
|
-$43.9M |